Neumann Mark Insider Trades

Insider Trading History

Track insider trading activity for Neumann Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.5M 102,196 shares
$131.87
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $1.73M 13,134 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 21,876 shares
$131.87
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$964k 7,345 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $7.38M 55,927 shares
Last Trade
Mar 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$964k 7,345 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $6.96M 52,811 shares
Last Trade
Mar 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$409k 3,116 shares
$131.24
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $1.73M 13,133 shares
Last Trade
Mar 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 13,133 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $6.41M 48,582 shares
Last Trade
Mar 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$731k 5,572 shares
$131.19
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $7.14M 54,154 shares
Last Trade
Mar 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 13,133 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $2.31M 17,485 shares
Last Trade
Mar 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 8,742 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $5.9M 44,730 shares
Last Trade
Mar 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 8,742 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $5.41M 41,021 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$475k 3,709 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $3M 22,727 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.89M 22,727 shares
$127.19
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $5.37M 40,717 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 11,017 shares
$127.08
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $4.75M 35,988 shares
Last Trade
Jan 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$601k 4,729 shares
$127.00
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Aug 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 18,714 shares
$74.83
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $6.38M 48,414 shares
Last Trade
Aug 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 18,714 shares
$74.83
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $3.92M 29,700 shares
Last Trade
Aug 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.41M 18,714 shares
$75.08
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $4.32M 32,742 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$482k 7,345 shares
$65.61
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $4.89M 37,045 shares
Last Trade
Mar 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$496k 7,345 shares
$67.48
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Commercial Officer
Holding Value $969k 7,345 shares
Last Trade
Mar 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$496k 7,345 shares
$67.48
$131.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up